| 28411509
|
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. |
Curr Opin Virol |
2017 |
Bauer L;Lyoo H;van der Schaar HM;Strating JR;van Kuppeveld FJ |
View
More |
| 28705625
|
Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo. |
Antiviral Res |
2017 |
Song JH;Kim SR;Heo EY;Lee JY;Kim DE;Cho S;Chang SY;Yoon BI;Seong J;Ko HJ |
View
More |
| 33713730
|
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. |
Antiviral Res |
2021 |
Milani M;Donalisio M;Bonotto RM;Schneider E;Arduino I;Boni F;Lembo D;Marcello A;Mastrangelo E |
View
More |
| 33895135
|
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells. |
J Biol Chem |
2021 |
Carpinteiro A;Gripp B;Hoffmann M;Pohlmann S;Hoertel N;Edwards MJ;Kamler M;Kornhuber J;Becker KA;Gulbins E |
View
More |
| 33961065
|
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19. |
Naunyn Schmiedebergs Arch Pharmacol |
2021 |
Raj K;Kaur K;Gupta GD;Singh S |
View
More |
| 34857794
|
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease. |
Sci Rep |
2021 |
Sugiyama MG;Cui H;Redka DS;Karimzadeh M;Rujas E;Maan H;Hayat S;Cheung K;Misra R;McPhee JB;Viirre RD;Haller A;Botelho RJ;Karshafian R;Sabatinos SA;Fairn GD;Madani Tonekaboni SA;Windemuth A;Julien JP;Shahani V;MacKinnon SS;Wang B;Antonescu CN |
View
More |
